-
Mashup Score: 3Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients - 9 day(s) ago
Blood Cancer Journal – Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Blood Cancer Journal – Long-term outcomes of allogeneic stem cell transplant in multiple myeloma
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Learn more about CAR T-Cell therapy, a breakthrough cancer treatment option offered at The University of Kansas Cancer Center in Kansas City.
Source: www.kucancercenter.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2
Our study revealed that patients who respond to DPd are at high risk of dose reduction or treatment interruption because of hematological toxicity, typically due to neutropenia and leukopenia leading to increased risk of hospitalization and pneumonia.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Menu - 12 day(s) ago
In the article Bone Tumors – Differential diagnosis we discuss a systematic approach to the differential diagnosis of bone tumors and tumor-like lesions. In this article we will discuss the differential diagnosis of well-defined osteolytic bone tumors and tumor-like lesions. Abbreviations used: On the left the most common well-defined bone tumors and tumor-like lesions. These lesions are sometimes referred to as benign cystic lesions, which is a misnomer since most of them are not cystic, except for SBC
Source: radiologyassistant.nlCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 38Paper: Global Access to Multiple Myeloma Medications (GLAMM-2 Study): Access and Barriers to Chemoimmunotherapies and Transplant - 13 day(s) ago
Program: Oral and Poster Abstracts Session: 652. Multiple Myeloma: Clinic al and Epidemiological: Poster III Hematology Disease Topics & Pathways: Research, Clinical Practice (Health Services and Quality), Clinical Research, health disparities research, Diseases, Therapies Aytaj Mammadzadeh 1,2 *, Yara Shatnawi, MD 2,3 *, Rawan Atallah 2,4 *, Benlazar Mohamed, MD 5 *, Nihar Desai, MBBS 6 *, Shahrukh K Hashmi, MD, MPH 7,8 *, Thiago Xavier Carneiro, MD 9 *, Hira Shaikh, MBBS 2,10 *, Christopher Strouse, MD
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet-
Global Access to Multiple Myeloma Medications (GLAMM-2 Study): Access & Barriers to Chemoimmunotherapies & Transplant worldwide https://t.co/08cRofbwXn ?ACCESS DENIED ? @OncoAlert #ASH23 @smbenlazar @nihardesai7 @hiragss @strouse_chris @DrRakeshPopat @kczmj @NausheenAhmedMD… https://t.co/F72cECoSoz https://t.co/blMGSYkD5n
-
-
Mashup Score: 4Mott Cell - 15 day(s) ago
Shoot for 150-160 chars
Source: imagebank.hematology.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
The Committee will discuss the use of minimal residual disease (MRD) as an endpoint in multiple myeloma clinical trials, including considerations regarding t…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1F1000Research Article: Advances in the understanding of IgM monoclonal gammopathy of undetermined significance. - 26 day(s) ago
Read the latest article version by Jonas Paludo, Stephen M Ansell, at F1000Research.
Source: f1000research.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 9Daratumumab‐based therapy for patients with monoclonal gammopathy of renal significance - 26 day(s) ago
An official journal of the British Society for Haematology, the British Journal of Haematology offers high visibility for clinical, basic and translational research.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet
https://t.co/WalavSB38A